Studies Paint Nuanced Picture of Insulin Out-of-Pocket Costs

Medicare enrollees this fall will be able to sign up for prescription plans that cap copayments for insulin at $35 a month. A recent Kaiser Family Foundation analysis shows that average annual out-of-pocket spending on insulin among Medicare Part D enrollees without low-income subsidies (LIS) increased from $324 in 2007 to $580 in 2017. Meanwhile, a new study in JAMA Internal Medicine found that insulin accounted for just 18% of all out-of-pocket spending among privately insured patients with type 1 diabetes in 2018 — and accounted for less out-of-pocket spending than diabetes-related supplies.

© 2023 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

doctor-speaking-to-a-patient
May 25

Commercial Insurance Restrictions Complicate Biosimilar Adoption

READ MORE
shell-game
May 25

‘Shell Game’ or Rebate Maximizers? FTC Probe Reignites Debate Over GPOs

Read More
pills-in-hand
May 25

As Weight Loss Drugs’ Star Rises, Plan Sponsors, Researchers Worry About Costs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today